CymaBay Therapeutics Inc. (CBAY) Social Stream
CYMABAY THERAPEUTICS INC (CBAY) Price Targets From Analysts
Use the tables below to see what analysts covering CYMABAY THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-17 | 8 | $14 | $7 | $11.125 | $19.13 | -41.85% |
| 2021-11-11 | 8 | $14 | $7 | $11.25 | $19.13 | -41.19% |
| 2022-03-18 | 8 | $14 | $9 | $11.375 | $19.13 | -40.54% |
| 2022-04-06 | 7 | $14 | $9.001 | $11.375 | $19.13 | -40.54% |
| 2022-05-13 | 7 | $14 | $7 | $11 | $19.13 | -42.5% |
| 2022-11-15 | 8 | $14 | $7 | $10.25 | $19.13 | -46.42% |
| 2022-12-14 | 8 | $14 | $8 | $10.25 | $19.13 | -46.42% |
| 2023-01-16 | 8 | $17 | $8 | $10.75 | $19.13 | -43.81% |
| 2023-01-31 | 8 | $19 | $8 | $12 | $19.13 | -37.27% |
| 2023-02-08 | 8 | $19 | $8 | $12.25 | $19.13 | -35.96% |
| 2023-03-16 | 8 | $19 | $8 | $12.5 | $19.13 | -34.66% |
| 2023-03-17 | 8 | $19 | $8 | $12.75 | $19.13 | -33.35% |
| 2023-03-20 | 9 | $19 | $8 | $13.375 | $19.13 | -30.08% |
| 2023-05-16 | 9 | $19 | $8 | $13.75 | $19.13 | -28.12% |
| 2023-06-30 | 9 | $19 | $8 | $14.25 | $19.13 | -25.51% |
| 2023-07-23 | 9 | $19 | $8 | $14.666 | $19.13 | -23.34% |
| 2023-07-31 | 10 | $19 | $12 | $15.555 | $19.13 | -18.69% |
| 2023-08-01 | 10 | $19 | $12 | $16.333 | $19.13 | -14.62% |
| 2023-08-11 | 11 | $20 | $12 | $16.7 | $19.13 | -12.7% |
| 2023-08-14 | 12 | $22 | $12 | $17.181 | $19.13 | -10.19% |
| 2023-08-24 | 12 | $22 | $15 | $18.181 | $19.13 | -4.96% |
| 2023-09-07 | 12 | $33 | $15 | $20.181 | $19.13 | 5.49% |
| 2023-09-08 | 12 | $33 | $18 | $21.909 | $19.13 | 14.53% |
| 2023-09-21 | 12 | $33 | $18 | $22.09 | $19.13 | 15.47% |
| 2023-09-26 | 12 | $33 | $19 | $22.727 | $19.13 | 18.8% |
| 2023-11-08 | 12 | $33 | $20 | $24 | $19.13 | 25.46% |
| 2023-11-09 | 12 | $34 | $20 | $24.454 | $19.13 | 27.83% |
The Trend in the Analyst Price Target
CBAY's average price target has moved up $12.45 over the prior 31 months.
CBAY reports an average of 45.27% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 7 | 19 | 8 | 12.250 | 8.41 | 45.66% |
| 2023-03-16 | 8 | 19 | 8 | 12.500 | 9.14 | 36.76% |
| 2023-03-20 | 9 | 19 | 8 | 13.375 | 9.51 | 40.64% |
| 2023-05-16 | 9 | 19 | 8 | 14.250 | 9.60 | 48.44% |
| 2023-11-09 | 12 | 34 | 20 | 24.454 | 14.86 | 64.56% |
CBAY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 12 | 0 | 0 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
CBAY's average broker recommendation rating improved by 0 over the prior 35 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CYMABAY THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 348.2% of them.
- CYMABAY THERAPEUTICS INC's number of analysts covering the stock is higher than 3326.04% of stocks in the small market cap category.
- CBAY has a higher average analyst price target than 932.8% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, CYMABAY THERAPEUTICS INC's variance in analysts' estimates is lower than -2316.38% of them.
In the Pharmaceutical Products industry, RMTI, RIGL, and ANIP are the three stocks most similar to CYMABAY THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CBAY a Buy, Hold or Sell? See the POWR Ratings now!